Table 2.
Funding Source | |||||
Direction and Statistical Significance of Trial Outcome | Industry ONLY | Not for Profit ONLY | Mixed + | Not Reported | TOTAL |
Favoured New | 30 | 15 | 16 | 6 | 67 |
Favoured Conventional | 4 | 1 | 1 | 0 | 6 |
Neutral | 6 | 9 | 4 | 0 | 19 |
Unclear | 4 | 3 | 1 | 0 | 8 |
Total | 44 | 28 | 22 | 6 | 100 |
p = .461 |
+ = funding by at least one industry source and at least one not-for-profit source